comment Q2 and IR firmThe market seems to want full booking for Q2. I said in earlier post that i did not expect much for this Qtr. I expect Q3 and Q4 to be very strong.... this is when all the billing will be sent. i still expect ADK to earn for the full fiscal Year ending March 31 2018 at least 6.6M in revenus and 1.2 to 1.6 in profits.
Also things are going well for cardio. we are about 6 months ahead of schedual.
plus we continue to get participation from some big pharmas into the development of our AI tech in cardio.
why is the market reacting like this? Management did say they are running the company on an yearly basis.... not quaterly.
plus finally the signing of an IR firm mostly for US market.... something we have been waiting for.
i strongly believe this is gonna be an opportunity to add at a very cheap price shares.
for the short term, it's gonna be a good clean up of the weak hands.
good luck to all
whippet